Episode
Kathleen Goin Cashes Out Palvella Shares
- Published
- Jun 27, 2026
- Duration seconds
- 98
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/kathleen-goin-cashes-out-palvella-shares/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/kathleen-goin-cashes-out-palvella-shares.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Kathleen Goin, Palvella Therapeutics’ COO, cashed out nearly half a million dollars by selling shares from recently exercised stock options, effectively zeroing out her direct stake—though she still holds over 17,000 options. The company, developing a topical rapamycin gel for rare skin disorders, saw its stock surge 620% in a year, closing at $148.21 after her sale at $110.73, despite ongoing net losses. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/b0c8a1c81b4b9723